Introduction
Sexual Health Inventory for Men (SHIM) is a validated questionnaire that is widely used in urology clinics to evaluate and assess treatment efficacy for erectile dysfunction (ED).
Aim
In this study, we evaluated the benefit of using the SHIM questionnaire as a screening tool for ED in a general urology clinic
Material and Methods
We retrospectively reviewed records of patients presenting to our general urology clinic from October 2018 to June 2019. During this period, all new male urology patients who are 40 years of age or older visiting the general urology clinic for any urologic condition received the SHIM questionnaire. We excluded all patients whose chief complaint was ED, Peyronie's disease, and hypogonadism. Patients were then asked if they want treatment for ED, and those patients who did, received a full ED evaluation and treatment. Factors associated with desire for ED treatment were analyzed using logistic regression.
Main Outcome Measures
SHIM score, desire for ED treatment, and factors influencing desire for treatment.
Results
Three hundred seventy-nine patients received the SHIM questionnaire. Of which, 48 patients (12.7%) declined to fill the questionnaire. We excluded all patients presenting for sexual health issues (67 patients, 17.7%). We included the remaining 264 patients (69.6%). The mean age was 61.7 years (range 40 to 85). Older patients were more likely to want ED treatment and had lower SHIM scores. However, older than the age of 70 years, there was a decline in the number of patients wanting treatment. In a multivariate regression analysis, age between 61 and 70 years and having diabetes mellitus were associated with the desire for ED treatment.
Conclusions
The SHIM questionnaire is a useful tool in the general urology clinic. It can serve as an efficient tool to screen for and quantify ED in patients presenting for other urologic issues. Maximum benefit is seen in patients between the age of 51 and 70 years and in patients with diabetes.
Alwaal A, Awad M, Boggs N, et al. Sexual Health Inventory for Men Questionnaire as a Screening Method for Erectile Dysfunction in a General Urology Clinic. Sex Med 2020;8:660–663.
INTRODUCTION AND OBJECTIVE: Computed-tomography with urography is the standard staging modality for patients with urothelial carcinoma undergoing radical cystectomy (RC). The current TNM classification for nodal stage seems to be insufficient in the prediction of prognosis whereas the ratio of positives lymph nodes (LN) in comparison to all dissected LNs (LNR) has been a new promising approach. Accurate staging is crucial for the planning for therapeutic options and prognosis. We investigated various CT scan characteristics in cNþ patients to further evaluate the LNR and its impact on oncological outcome.METHODS: We analyzed preoperative CT scans of 764 cN0 and 166 cNþ patients undergoing RC in a academic center. Retrospectively, we investigated local tumor stage and LN characteristics such as size, morphology (MLN) and number (NLN) for cNþ patients. Correlation between CT scan criteria, LNR and survival were investigated using Kaplan-Maier and multivariate analysis.RESULTS: Correlation for significant higher LNR in cNþ patients was only revealed for LN size >15mm (p[0.002). Increased number of loco-regional LNs in CT scan correlates with decreased CSS and OS (p[0.001: p[0.002). Furthermore, CT scan based scoring system precisely differentiates low-risk and high-risk profiles to predict oncological outcome (p <0.001).CONCLUSIONS: In our study, solely LN size >15mm significantly correlated with higher LNR. The increased number of locoregional LN was associated with worse survival. To the first time, CT scan based scoring system predicts oncological outcome for clinical lymph node-positive patients undergoing RC.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.